119 related articles for article (PubMed ID: 12804927)
1. Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment.
Dibra A; Mehilli J; Schwaiger M; Schühlen H; Bollwein H; Braun S; Neverve J; Schömig A; Kastrati A
Eur Heart J; 2003 Jun; 24(12):1128-33. PubMed ID: 12804927
[TBL] [Abstract][Full Text] [Related]
2. Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis.
Dibra A; Mehilli J; Dirschinger J; Pache J; Neverve J; Schwaiger M; Schömig A; Kastrati A
J Am Coll Cardiol; 2003 Mar; 41(6):925-9. PubMed ID: 12651035
[TBL] [Abstract][Full Text] [Related]
3. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
Kastrati A; Mehilli J; Dirschinger J; Schricke U; Neverve J; Pache J; Martinoff S; Neumann FJ; Nekolla S; Blasini R; Seyfarth M; Schwaiger M; Schömig A;
Lancet; 2002 Mar; 359(9310):920-5. PubMed ID: 11918909
[TBL] [Abstract][Full Text] [Related]
4. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.
Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M
N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737
[TBL] [Abstract][Full Text] [Related]
5. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
[TBL] [Abstract][Full Text] [Related]
6. Myocardial salvage after reduced-dose thrombolysis combined with glycoprotein IIb/IIIa blockade versus thrombolysis alone in patients with acute myocardial infarction.
Ndrepepa G; Mehilli J; Schwaiger M; Nekolla S; Schmitt C; Dirschinger J; Schömig A; Kastrati A
J Thromb Thrombolysis; 2004 Jun; 17(3):191-7. PubMed ID: 15353917
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction.
Sibbing D; von Beckerath O; von Beckerath N; Koch W; Mehilli J; Schwaiger M; Schömig A; Kastrati A
Blood Coagul Fibrinolysis; 2005 Oct; 16(7):511-5. PubMed ID: 16175011
[TBL] [Abstract][Full Text] [Related]
8. Gated SPECT evaluation of the relationship between admission troponin I, myocardial salvage, and functional recovery in acute myocardial infarction treated by abciximab and early primary angioplasty.
Leoncini M; Bellandi F; Sciagrà R; Maioli M; Toso A; Coppola A; Sestini S; Mennuti A; Dabizzi RP; Pupi A
J Nucl Med; 2004 May; 45(5):739-44. PubMed ID: 15136620
[TBL] [Abstract][Full Text] [Related]
9. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy.
Dong J; Ndrepepa G; Schmitt C; Mehilli J; Schmieder S; Schwaiger M; Schömig A; Kastrati A
Circulation; 2002 Jun; 105(25):2946-9. PubMed ID: 12081985
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.
Antoniucci D; Rodriguez A; Hempel A; Valenti R; Migliorini A; Vigo F; Parodi G; Fernandez-Pereira C; Moschi G; Bartorelli A; Santoro GM; Bolognese L; Colombo A
J Am Coll Cardiol; 2003 Dec; 42(11):1879-85. PubMed ID: 14662245
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
[TBL] [Abstract][Full Text] [Related]
12. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
13. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
Valgimigli M; Percoco G; Malagutti P; Campo G; Ferrari F; Barbieri D; Cicchitelli G; McFadden EP; Merlini F; Ansani L; Guardigli G; Bettini A; Parrinello G; Boersma E; Ferrari R;
JAMA; 2005 May; 293(17):2109-17. PubMed ID: 15870414
[TBL] [Abstract][Full Text] [Related]
14. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone.
Antoniucci D; Migliorini A; Parodi G; Valenti R; Rodriguez A; Hempel A; Memisha G; Santoro GM
Circulation; 2004 Apr; 109(14):1704-6. PubMed ID: 15066943
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.
Ndrepepa G; Mehilli J; Schwaiger M; Schühlen H; Nekolla S; Martinoff S; Schmitt C; Dirschinger J; Schömig A; Kastrati A
J Nucl Med; 2004 May; 45(5):725-9. PubMed ID: 15136618
[TBL] [Abstract][Full Text] [Related]
16. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
[TBL] [Abstract][Full Text] [Related]
17. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.
Lenderink T; Boersma E; Heeschen C; Vahanian A; de Boer MJ; Umans V; van den Brand MJ; Hamm CW; Simoons ML;
Eur Heart J; 2003 Jan; 24(1):77-85. PubMed ID: 12559939
[TBL] [Abstract][Full Text] [Related]
18. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
Mehilli J; Kastrati A; Schulz S; Früngel S; Nekolla SG; Moshage W; Dotzer F; Huber K; Pache J; Dirschinger J; Seyfarth M; Martinoff S; Schwaiger M; Schömig A;
Circulation; 2009 Apr; 119(14):1933-40. PubMed ID: 19332467
[TBL] [Abstract][Full Text] [Related]
19. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.
Pache J; Kastrati A; Mehilli J; Bollwein H; Ndrepepa G; Schühlen H; Martinoff S; Seyfarth M; Nekolla S; Dirschinger J; Schwaiger M; Schömig A
Am Heart J; 2004 Jul; 148(1):e3. PubMed ID: 15215812
[TBL] [Abstract][Full Text] [Related]
20. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.
Gyöngyösi M; Domanovits H; Benzer W; Haugk M; Heinisch B; Sodeck G; Hödl R; Gaul G; Bonner G; Wojta J; Laggner A; Glogar D; Huber K;
Eur Heart J; 2004 Dec; 25(23):2125-33. PubMed ID: 15571828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
